XINGLU WATER (02281) announces that the net profit attributable to shareholders for 2025 is expected to be approximately 109 million yuan, a decrease of about 38.4% year-on-year.
Xinglushui Water (02281) announced its performance in 2025, with its operating income at around 1.237 billion yuan, a decrease of about 7% from the same period in 2024. The net profit attributable to the owner of the parent company is around 109 million yuan, a decrease of about 38.4% from the same period in 2024. The basic earnings per share is around 0.13 yuan, and the final dividend per share is 0.04 yuan.
XINGLU WATER (02281) announced its performance for the year 2025, with operating income of approximately 1.237 billion yuan, a decrease of about 7% compared to the same period in 2024. Net profit attributable to owners of the parent company is approximately 109 million yuan, a decrease of about 38.4% compared to the same period in 2024. Basic earnings per share are about 0.13 yuan, with a final dividend of 0.04 yuan per share.
The announcement stated that the main reasons for the decrease in revenue are due to a decrease in engineering installation income, and the impact of canceling the service fees for secondary water supply of tap water.
Related Articles

SV VISION (08429) announced its annual performance, with a net loss attributable to shareholders of HK$10.239 million, an increase of 2.46% year-on-year.

HARBOUR EQUINE (08377) is expected to have a net loss of approximately HK$4.2 million in 2025.

BOLTEK (08601) released its annual performance with a net profit attributable to shareholders of HK$22.576 million, a decrease of 19.53% year-on-year.
SV VISION (08429) announced its annual performance, with a net loss attributable to shareholders of HK$10.239 million, an increase of 2.46% year-on-year.

HARBOUR EQUINE (08377) is expected to have a net loss of approximately HK$4.2 million in 2025.

BOLTEK (08601) released its annual performance with a net profit attributable to shareholders of HK$22.576 million, a decrease of 19.53% year-on-year.

RECOMMEND

Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026

Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026

Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026


